FDA-approved small-molecule kinase inhibitors.
By Peng Wu, Thomas E. Nielsen, M. Clausen. TIPS - Trends in Pharmacological Sciences, 2015
910 citations recorded by the source corpus.
Kinases have emerged as one of the most intensively pursued targets in current pharmacological research, especially for cancer, due to their critical roles in cellular signaling. To date, the US FDA has approved 28 small-molecule kinase inhibitors, half of which were approved in the past 3 years. While the clinical data of these approved molecules are widely presented and structure-activity relationship (SAR) has been reported for individual molecules, an updated review that analyzes all approved molecules and summarizes current achievements and trends in the field has yet to be found. Here we present all approved small-molecule kinase inhibitors with an emphasis on binding mechanism and structural features, summarize current challenges, and discuss future directions in this field.
Subfields: Genetics, Molecular Biology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/36dbb08e8a91e0d21d13383d7590448731dc1346
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- An Integrated Mechanistic Model of Pan-Cancer Driver Pathways Predicts Stochastic Proliferation and Death (2017, background): “With now hundreds of FDA-approved anti-cancer therapeutics (including dozens of targeted drugs), and the realization that combination therapy is almost always required for clinical response, computational approaches such as this that help prioritize drugs, their doses, and their scheduling for parti”
- The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins (2016, background): “Predicting substrates of kinases Protein kinases are well-studied enzymes that regulate almost all cellular processes by reversible phosphorylation of their substrates (149, 150).”
- Targeting Free Radicals in Oxidative Stress-Related Human Diseases. (2017, background): “The beneficial effects of ROS/RNS tend to occur at low to moderate concentrations and involve their participation in various physiological roles and in numerous cellular signaling pathways [6].”